APOL1 risk variants, race, and progression of chronic kidney disease - Wikidata - wikimedia - TriplyDB

APOL1 risk variants, race, and progression of chronic kidney disease

APOL1 risk variants, race, and progression of chronic kidney disease

http://www.wikidata.org/entity/Q34383679

about

Ethnic Differences in Childhood Nephrotic Syndrome APOL1 Kidney Disease Risk Variants: An Evolving Landscape Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era Kidney disease: new technologies translate mechanisms to cure Disparities in the burden, outcomes, and care of chronic kidney disease Recent advances in understanding of chronic kidney disease Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory Socioeconomic disparities in chronic kidney disease Developments in renal pharmacogenomics and applications in chronic kidney disease Clinical perspectives on lupus genetics: advances and opportunities Addressing the global burden of chronic kidney disease through clinical and translational research Pro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapy APOL1 kidney risk alleles: population genetics and disease associations Renal autoregulation in health and disease Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited Food Access, Chronic Kidney Disease, and Hypertension in the U.S In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).Examining How Our Shared Evolutionary History Shapes Future Disease Outcomes.Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.Insights into kidney diseases from genome-wide association studies.Social Determinants of Racial Disparities in CKD.Genome-wide association studies in pediatric chronic kidney disease.Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.Testing the trajectory difference in a semi-parametric longitudinal model.Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association Return of results in the genomic medicine projects of the eMERGE network Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Genome-wide association studies in nephrology: using known associations for data checks Disease progression subtype discovery from longitudinal EMR data with a majority of missing values and unknown initial time points Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.Research capacity. Enabling the genomic revolution in Africa.Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model African Americans, hypertension and the renin angiotensin system

P2860

Q26752347-10A0ED07-9726-4988-B8A7-6A3960593E20 Q26799191-BFEC4AE4-E2CA-4E00-86EB-CF9D384C3CDD Q26799197-6B279B43-0E18-4A3D-88F3-19920E57B37C Q26825227-C9FF260D-115F-4389-9B1D-6E39981161C9 Q26825597-25D8FA6A-BD15-4F3E-890E-74E3E92D7D16 Q26827631-A24B9155-C83A-491F-95AB-7596DF865228 Q26862794-9713AE46-0821-4BE1-9091-F6A0113D1C39 Q26991562-77994B82-49C3-49F6-BCC7-AD8F2C34EECB Q26999279-937223ED-22E5-4702-94BF-B58F621ED7BC Q27001690-A76F6438-DD40-4E2B-83B2-55353607C814 Q27014158-E9DA0848-B113-4C90-8BD8-EE52CF60E096 Q27015909-90C60CEB-7F13-4AB7-9DE8-8DA6DF4C28A5 Q27024261-E3261979-95A7-48E9-84EA-24AE9D2AB3F8 Q28082365-09933F1E-D670-4AD6-A657-5421301976F6 Q28083698-9FF01632-2B45-4A84-91BA-B8F8D1E27D13 Q28270065-C7FCDC78-9606-47BD-8CE6-3114C069C93B Q28546164-02F78709-5184-4E31-BDBC-D8BF442C200A Q28606687-14F05BA7-8407-4051-A9BF-83ECB49966FB Q30235179-3EA80636-DFD6-4CAB-968D-F74167BD2E41 Q30235244-DA9FF68F-DFFC-4AE6-B65F-F1AE943BDD2F Q30235345-0DFD3A2F-4A9B-44D1-ADD1-E1B138DF9DD1 Q30248678-8840C2A9-11BF-443C-9A40-FA26E00A170A Q30250319-D8BD3FE0-DA9D-410C-B460-CFAC2BC0648C Q30252068-95F7E10A-F115-4EFA-9D5F-CE4CF49DB8F6 Q30277219-1AB87518-2080-4BDC-8D90-7D303439F9DF Q30279056-48330A95-940E-4457-88F8-BD71E4E38291 Q30299953-E03542D8-A0D1-4598-8B36-EBF05D5E3F4C Q30301317-2DBDBB52-7F06-4F13-892D-A09FC28769A7 Q30359344-3F3EB116-A690-44E8-9C03-BF5630DA574C Q30359686-E858893C-13E2-4A36-91E8-09BDC1D3E0D5 Q30575241-4F6FC80C-9209-4443-9FC2-A5CED7947CC7 Q30860042-6DC08780-84B0-4323-8208-3147DB2C033E Q30873838-72E37122-95E8-4CE8-B9D2-849BDE53AE60 Q30946911-96C17361-F04E-458B-90FA-D8F54E056382 Q33715840-D6035881-1D9F-4A05-AEF0-964EC5C93F9B Q33752285-357428E7-0C5C-48C0-AE63-C29C5B68CBE7 Q34008876-23A47193-A91A-41C8-BD07-2A7806E193A6 Q34068017-0B696BC2-537A-4D54-8C38-2C907A15358A Q34173320-C7DE71AF-B52B-4424-9245-4B1CBC00036D Q34251854-79023B14-5750-447F-B511-EAA7D2D84DE9

P2860

APOL1 risk variants, race, and progression of chronic kidney disease

http://www.wikidata.org/entity/Q34383679

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

APOL1 risk variants, race, and progression of chronic kidney disease

@ast

APOL1 risk variants, race, and progression of chronic kidney disease

@en

APOL1 risk variants, race, and progression of chronic kidney disease

@nl

type

label

APOL1 risk variants, race, and progression of chronic kidney disease

@ast

APOL1 risk variants, race, and progression of chronic kidney disease

@en

APOL1 risk variants, race, and progression of chronic kidney disease

@nl

prefLabel

APOL1 risk variants, race, and progression of chronic kidney disease

@ast

APOL1 risk variants, race, and progression of chronic kidney disease

@en

APOL1 risk variants, race, and progression of chronic kidney disease

@nl

P1433

Q34383679-C23F77EC-E326-493A-8E9A-3D694DDCC1B8

P1476

Q34383679-AF942F7A-A8A1-465B-BF90-17EEBBA81247

P2093

Q34383679-1207DD91-7F32-4D24-A9F0-CE2606FDBD99

Q34383679-13383DF2-A8E3-44ED-B1E9-1DD3788D737B

Q34383679-2AAFD171-C745-4B29-BDD4-7CFCD0E5705F

Q34383679-431F1353-9BF5-4F5E-AB9F-FD1784CEDB32

Q34383679-4BEACD15-B8FE-46C7-B182-BCDDE7934603

Q34383679-5127ECCF-5F8F-4C73-BD8F-D41B8479173F

Q34383679-58826224-C4F4-471A-9F65-7C5A5A9EE05D

Q34383679-6594DD8D-C250-4ECD-BBCC-598E200028B5

Q34383679-6C7B9C95-E3DE-4F0C-8DE9-4546E85048DF

Q34383679-6CD91D61-1BA2-4B87-AC89-547A9A659D50

P2860

Q34383679-054FF6BA-11D7-4C41-8991-87BDD000FB01

Q34383679-0C0CCB12-2606-420C-8629-888B5545FA04

Q34383679-0E56FFC0-58D8-478E-BE71-441E50B22E23

Q34383679-10B86220-A4E8-4A22-8CCA-5E63AC6FB5CA

Q34383679-139903E7-D565-450C-AD5C-458E052F35E0

Q34383679-1754CABF-603A-45E4-A088-FE5650214ECB

Q34383679-176E3AD3-5C66-49CF-A54D-25FB25B17721

Q34383679-2793B1DE-6487-42DF-8E6F-8A9F5B047064

Q34383679-319F5B3A-FE42-4B90-844C-C6E4C4368A99

Q34383679-3A3BB3E3-08BA-47A9-87AD-7C2FF4611C90

P304

Q34383679-5C659A71-ADDA-4CF3-9F12-3B6703F05657

P31

Q34383679-E32533D9-020F-472B-8855-101C462E4838

P356

Q34383679-AEE0D2E1-4113-4106-B8AC-7FA084844690

P407

Q34383679-2CA5F8D9-5A3B-4E9F-874F-AA09D5F083AC

P433

Q34383679-6D679EC3-F050-4AE6-9819-48B6CD723FDA

P478

Q34383679-E253628A-552F-46F7-8270-264A93BFD9A8

P50

Q34383679-9A603E15-F768-4A95-B488-364D947935CE

Q34383679-C8A1769B-9F91-43EA-AD80-D94F6038AA34

Q34383679-D3B89A1F-AAA8-4C07-B5D3-8EB004C0FE52

Q34383679-F608CDC6-C57A-4FCE-B1BD-B9BA912F67D7

P577

Q34383679-0AA8FDDD-E571-4A23-AA4F-E44FBB7B569C

P5875

Q34383679-523DBD54-450F-4F2A-B3B0-61DE8348D42D

P698

Q34383679-72594342-6457-48C1-A584-FE227755FA40

P932

Q34383679-1A3E12AC-D1C2-4C85-9CA2-7A112E26A13B

P356

P1433

The New England Journal of Medicine

P1476

APOL1 risk variants, race, and progression of chronic kidney disease

@en

P2093

AASK Study Investigators

http://www.w3.org/2001/XMLSchema#string

Afshin Parsa

http://www.w3.org/2001/XMLSchema#string

Akinlolu Ojo

http://www.w3.org/2001/XMLSchema#string

Amanda H Anderson

http://www.w3.org/2001/XMLSchema#string

Barry I Freedman

http://www.w3.org/2001/XMLSchema#string

Brad C Astor

http://www.w3.org/2001/XMLSchema#string

Cheryl A Winkler

http://www.w3.org/2001/XMLSchema#string

Chi-yuan Hsu

http://www.w3.org/2001/XMLSchema#string

Dawei Xie

http://www.w3.org/2001/XMLSchema#string

Dominic S Raj

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated map of genetic variation from 1,092 human genomes

Apolipoprotein L-I is the trypanosome lytic factor of human serum

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

The APOL1 gene and allograft survival after kidney transplantation

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

APOL1 localization in normal kidney and nondiabetic kidney disease

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

P304

2183-2196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1310345

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey B. Kopp

Jeffrey C. Fink

CRIC Study Investigators

P577

2013-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258438612

http://www.w3.org/2001/XMLSchema#string

P698

24206458

http://www.w3.org/2001/XMLSchema#string

P932

3969022

http://www.w3.org/2001/XMLSchema#string